Chronic constipation in the elderly: A primer for the gastroenterologist

BMC Gastroenterology

Volumn 15, Issue 1, 2015, Pages

  De Giorgio, Roberto ^a   Ruggeri, Eugenio ^a   Stanghellini, Vincenzo ^a   Eusebi, Leonardo H ^a   Bazzoli, Franco ^a   Chiarioni, Giuseppe ^b,c,d  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY HOSPITAL OF VERONA   (Italy)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF VERONA   (Italy)

Author keywords

Constipation; Elderly; Fecal impaction; Irritable bowel syndrome; Laxatives

Indexed keywords

ANTHRAQUINONE DERIVATIVE; BISACODYL; DOCUSATE SODIUM; ELOBIXIBAT; ISPAGULA; LACTITOL; LACTULOSE; LAXATIVE; LINACLOTIDE; LINACLOTIDE PLECANATIDE; LIQUID PARAFFIN; LUBIPROSTONE; MACROGOL; MAGNESIUM HYDROXIDE; NORCISAPRIDE; PICOSULFATE SODIUM; PLACEBO; PLECANATIDE; POLYCARBOPHIL CALCIUM; PROBIOTIC AGENT; PRUCALOPRIDE; SORBITOL; UNCLASSIFIED DRUG; VELUSETRAG;

ABDOMINAL CRAMP; ABDOMINAL DISCOMFORT; ABDOMINAL DISTENSION; ABDOMINAL PAIN; AGING; ANORECTAL DISEASE; ANXIETY DISORDER; BARIUM ENEMA; BLOATING; CARDIOVASCULAR FUNCTION; CHRONIC CONSTIPATION; COLON RESECTION; CONSTIPATION; DAILY LIFE ACTIVITY; DEFECATION; DEFECOGRAPHY; DEPRESSION; DIARRHEA; DIET SUPPLEMENTATION; DIFFERENTIAL DIAGNOSIS; DIGITAL RECTAL EXAMINATION; DISEASE ASSOCIATION; DRUG ACTIVITY; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG METABOLISM; DRUG PROTEIN BINDING; DRUG SAFETY; DRUG TOLERABILITY; ELDERLY CARE; ELECTROLYTE DISTURBANCE; ELECTROMYOGRAPHY; EMOTION; FECES INCONTINENCE; FEEDBACK SYSTEM; FLATULENCE; FLUID INTAKE; GASTROENTEROLOGIST; GASTROINTESTINAL MOTILITY; HARD FECES; HEADACHE; HEALTH CARE COST; HIGH FIBER DIET; HOSPITALIZATION; HUMAN; HYDROELECTROLYTIC ALTERATION; INFLAMMATORY BOWEL DISEASE; LACTOBACILLUS ACIDOPHILUS; LIFESTYLE MODIFICATION; LONG TERM CARE; LOW DRUG DOSE; MENTAL HEALTH; META ANALYSIS (TOPIC); MOTOR ACTIVITY; MULTIPLE CYCLE TREATMENT; NAUSEA; PATHOGENESIS; PATHOPHYSIOLOGY; PATIENT CARE; PELVIC FLOOR MUSCLE TRAINING; PHYSICAL ACTIVITY; PREVALENCE; PSYCHOLOGICAL GENERAL WELL-BEING INDEX; PSYCHOMETRY; PSYCHOSIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECTUM DISEASE; REVIEW; RISK FACTOR; SELF REPORT; SEX DIFFERENCE; SINGLE DRUG DOSE; SOCIAL STATUS; SOMATIZATION; STOMACH EMPTYING; STRAINING TRAINING; SUPPOSITORY; TREATMENT DURATION; TREATMENT OUTCOME; WELLBEING; AGED; CHRONIC DISEASE; FRAIL ELDERLY; GASTROENTEROLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AGING; CHRONIC DISEASE; CONSTIPATION; FRAIL ELDERLY; GASTROENTEROLOGY; HUMANS; QUALITY OF LIFE;

EID: 84944401340     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/s12876-015-0366-3     Document Type: Review

References (94)

1. Higgins PD, Johanson JF. Epidemiology of constipation in North America: a systematic review. Am J Gastroenterol. 2004;99:750-9.
2. Bharucha AE, Pemberton JH, Locke III GR. American Gastroenterological Association technical review on constipation. Am Gastroenterol Assoc Gastroenterol. 2013;144:218-38.
3. Glia A, Lindberg G. Quality of life in patients with different types of functional constipation. Scand J Gastroenterol. 1997;32:1083-9.
4. Wald A, Scarpignato C, Kamm MA. The burden of constipation on quality of life: results of a multinational survey. Aliment Pharmacol Ther. 2007;26:227-36.
5. Charach G, Greenstein A, Rabinovich P, Groskopf I, Weintraub M. Alleviating constipation in the elderly improves lower urinary tract symptoms. Gerontology. 2001;47:72-6.
6. Berardi RS, Lee S. Stercoraceous perforation of the colon. Report of a case. Dis Colon Rectum. 1983;26:283-6.
7. Wrenn K. Fecal impaction. N Engl J Med. 1989;321:658-62.
8. Bharucha AE, Dorn SD, Lembo A, Pressman A. American gastroenterological association medical position statement on constipation. Gastroenterology. 2013;144:211-7.
9. Neri L, Basilisco G, Corazziari E. Constipation severity is associated with productivity losses and healthcare utilization in patients with chronic constipation. United European Gastroenterol J. 2014;2:138-47.
10. Dennison C, Prasad M, Lloyd A, Bhattacharyya SK, Dhawan R, Coyne K. The health-related quality of life and economic burden of constipation. Pharmacoeconomics. 2005;23:461-76.
11. Menees SB, Guentner A, Chey SW, Saad R, Chey WD. How Do US Gastroenterologists Use Over-the-Counter and Prescription Medications in Patients With Gastroesophageal Reflux and Chronic Constipation?. Am J Gastroenterol 2015, in press.
12. Harari D. Constipation. In: Halter JB, Ouslander JG, Tinetti ME, editors. Hazzard's Geriatric Medicine and Gerontology. 6th ed. New York, USA: McGraw-Hill Companies; 2009. p. 1103-22.
13. Harris LA. Prevalence and ramifications of chronic constipation. Manag Care Interface. 2005;18:23-30.
14. Whitehead WE, Drinkwater D, Cheskin LJ, Heller BR, Schuster MMJ. Constipation in the elderly living at home. Definition, prevalence, and relationship to lifestyle and health status. Am Geriatr Soc. 1989;37:423-9.
15. Morley JE, Kim MJ, Haren MT, Kevorkian R, Banks WA. Frailty and the aging male. Aging male. 2005;8(3-4):135-40.
16. Wolfsen CR, Barker JC, Mitteness LS. Constipation in the daily lives of frail elderly people. Arch Fam Med. 1993;2:853-8.
17. Fox JC, Fletcher JG, Zinsmeister AR, Seider B, Riederer SJ, Bharucha AE. Effect of aging on anorectal and pelvic floor functions in females. Dis Colon Rectum. 2006;49:1726-35.
18. Werta BL, Williams KA, Pont LG. A longitudinal study of constipation and laxative use in a community-dwelling elderly population. Arch Gerontol Gertiatr. 2015, in press
19. Crane SJ, Talley NJ. Chronic gastrointestinal symptoms in the elderly. Clin Geriatr Med. 2007;23:721-34.
20. Kimberly BS. Constipation in the elderly: implication in skilled nursing facilities. Director. 2007;15:20-3.
21. Coyne KS, Cash B, Kopp Z, Murphy S, Smith GJ, Davidson GA. The prevalence of chronic constipation and fecal incontinence among men and women with symptoms of overactive bladder. BJU Int. 2011;107:254-61.
22. Bouras EP, Tangalos EG. Chronic constipation in the elderly. Gastroenterol Clin North Am. 2009;38:463-80.
23. Kinnunen O. Study of constipation in a geriatric hospital, day hospital, old people's home and at home. Aging. 1991;3:161-70.
24. Lim SF, Ong SY, Tan YL, Ng YS, Chan YH, Childs C. Incidence and predictors of new-onset constipation during acute hospitalisation after stroke. Int J Clin Pract 2015, in press doi: 10.1111/ijcp.12528
25. Rao SS, Seaton K, Miller MJ, et al. Psychological profiles and quality of life differ between patients with dyssynergia and those with slow transit constipation. J Psychosom Res. 2007;63:441-9.
26. O'Keefe EA, Talley NJ, Tangalos EG, Zinsmeister AR. A bowel symptom questionnaire for the elderly. J Gerontol. 1992;47:M116-21.
27. Talley NJ. Definitions, epidemiology, and impact of chronic constipation. Rev Gastroenterol Disord. 2004;4 Suppl 2:S3-10.
28. Pare P, Ferrazzi S, Thompson WG, Irvine EJ, Rance L. An epidemiological survey of constipation in Canada: definitions, rates, demographics, and predictors of health care seeking. Am J Gastroenterol. 2001;96:3130-7.
29. Bassotti G, Chiarioni G, Vantini I, et al. Anorectal manometric abnormalities and colonic propulsive impairment in patients with severe chronic idiopathic constipation. Dig Dis Sci. 1994;39:1558-64.
30. Cook IJ, Talley NJ, Benninga MA, Rao SS, Scott SM. Chronic constipation: overview and challenges. Neurogastroenterol Motil. 2009;21 Suppl 2:1-8.
31. Rao SS. Constipation: evaluation and treatment of colonic and anorectal motility disorders. Gastroenterol Clin North Am. 2007;36:687-711.
32. Koch TR, Carney JA, Go VL, Szurszewski JH. Inhibitory neuropeptides and intrinsic inhibitory innervation of descending human colon. Dig Dis Sci. 1991;36:712-8.
33. Bassotti G, Villanacci V. Can "functional" constipation be considered as a form of enteric neuro-gliopathy? Glia. 2011;59:345-50.
34. Camilleri M, Lee JS, Viramontes B, Bharucha AE, Tangalos EG. Insights into the pathophysiology and mechanisms of constipation, irritable bowel syndrome, and diverticulosis in older people. J Am Geriatr Soc. 2000;48:1142-50.
35. Varma JS, Bradnock J, Smith RG, Smith AN. Constipation in the elderly. A physiologic study. Dis Colon Rectum. 1988;31:111-5.
36. Knowles CH, Farrugia G. Gastrointestinal neuromuscular pathology in chronic constipation. Best Pract Res Clin Gastroenterol. 2011;25:43-57.
37. Szurszewski JH, Holt PR, Schuster M. Proceedings of a workshop entitled "Neuromuscular function and dysfunction of the gastrointestinal tract in aging". Dig Dis Sci. 1989;34:1135-46.
38. Klosterhalfen B, Offner F, Topf N, Vogel P, Mittermayer C. Sclerosis of the internal anal sphincter, a process of aging. Dis Colon Rectum. 1990;33:606-9.
39. Papachrysostomou M, Pye SD, Wild SR, Smith AN. Significance of the thickness of the anal sphincters with age and its relevance in fecal incontinence. Scand J Gastroenterol. 1994;29:710-4.
40. Lovell R, Ford A. Global prevalence of, and risk factors for, irritable bowel syndrome: a meta- analysis. Clin Gastroenterol Hepatol. 2012;10:712-21.
41. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology. 2006;130:1480-9.
42. Bassotti G, Maggio D, Battaglia E, et al. Manometric investigation of anorectal function in early and late stage Parkinson's disease. J Neurol Neurosurg Psychiatry. 2000;68:768-70.
43. Iovino P, Chiarioni G, Bilancio G, et al. New onset of constipation during long-term physical inactivity: a proof-of-concept study on the immobility-induced bowel changes. PLoS One. 2013;20:e72608.
44. Spiller R, Camilleri M, Longstreth GF. Do the symptom-based, Rome criteria of irritable bowel syndrome lead to better diagnosis and treatment outcomes? Clin Gastroenterol Hepatol. 2010;8:125-9.
45. Saad RJ, Rao SS, Koch KL, et al. Do stool form and frequency correlate with whole-gut and colonic transit? Results from a multicenter study in constipated individuals and healthy controls. Am J Gastroenterol. 2010;105:403-11.
46. Chiarioni G, Kim SM, Vantini I, Whitehead WE. Validation of the balloon evacuation test: reproducibility and agreement with findings from anorectal manometry and electromyography. Clin Gastroenterol Hepatol. 2014;12:2049-54.
47. Tack J, Müller-Lissner S, Stanghellini V. Diagnosis and treatment of chronic constipation--a European perspective. Neurogastroenterol Motil. 2011;23:697-710.
48. Bassotti G, Stanghellini V, Chiarioni G, et al. Upper gastrointestinal motor activity in patients with slow-transit constipation. Further evidence for an enteric neuropathy. Dig Dis Sci. 1996;41:1999-2005.
49. Redmond JM, Smith GW, Barofsky I, Ratych RE, Goldsborough DC, Schuster MM. Physiological tests to predict long-term outcome of total abdominal colectomy for intractable constipation. Am J Gastroenterol. 1995;90:748-53.
50. Arora Z, Parungao JM, Lopez R, Heinlein C, Santisi J, Birgisson S. Clinical Utility of Wireless Motility Capsule in Patients with Suspected Multiregional Gastrointestinal Dysmotility. Dig Dis Sci. 2015;60:1350-7.
51. Chiarioni G, Heymen S, Whitehead WE. Biofeedback therapy for dyssynergic defecation. World J Gastroenterol. 2006;12:7069-74.
52. Andersson H, Bosaeus I, Falkheden T, Melkersson M. Transit time in constipated geriatric patients during treatment with a bulk laxative and bran: a comparison. Scand J Gastroenterol. 1979;14:821-6.
53. Nour-Eldein H, Salama HM, Abdulmajeed AA, Heissam KS. The effect of lifestyle modification on severity of constipation and quality of life of elders in nursing homes at Ismailia city, Egypt. J Family Community Med. 2014;21:100-6.
54. Ford AC, Moayyedi P, Lacy BE, et al. American College of Gastroenterology Monograph on the Management of Irritable Bowel Syndrome and Chronic Idiopathic Constipation. Am J Gastroenterol. 2014;109:S2-26.
55. Spinzi G, Amato A, Imperiali G, et al. Constipation in the elderly: management strategies. Drugs Aging. 2009;26:469-74.
56. Suares NC, Ford AC. Systematic review: the effects of fibre in the management of chronic idiopathic constipation. Aliment Pharmacol Ther. 2011;33:895-901.
57. Fleming V, Wade WE. A review of laxative therapies for treatment of chronic constipation in older adults. Am J Geriatr Pharmacother. 2010;8:514-50.
58. Attaluri A, Donahoe R, Valestin J, Brown K, Rao SSC. Randomised clinical trial: dried plums (prunes) vs. psyllium for constipation. Aliment Pharmacol Ther. 2011;33:822-8.
59. Miller LE, Ouwehand AC. Probiotic supplementation decreases intestinal transit time: meta-analysis of randomized controlled trials. World J Gastroenterol. 2013;19:4718-25.
60. Chiarioni G, Whitehead WE. Biofeedback therapy for constipation. In: Parkman HP, McCallum RW, Rao SSC, editors. GI Motility Testing: a Laboratory and Office Handbook. Thorofare, NJ: Slack Inc; 2011. p. 179-87.
61. Simón MA, Bueno AM. Behavioural treatment of the dyssynergic defecation in chronically constipated elderly patients: a randomized controlled trial. Appl Psychophysiol Biofeedback. 2009;34:273-7.
62. Rao SSC, Go JT. Update on the management of constipation in the elderly: new treatment options. Clin Interv Aging. 2010;5:163-71.
63. Passmore AP, Davies KW, Flanagan PG, Stoker C, Scott MG. A comparison of Agiolax and lactulose in elderly patients with chronic constipation. Pharmacology. 1993;47 Suppl 1:249-52.
64. Connolly P, Hughes IW, Ryan G. Comparison of "Duphalac" and "irritant" laxatives during and after treatment of chronic constipation: a preliminary study. Curr Med Res Opin. 1975;2:620-5.
65. Lederle FA, Busch DL, Mattox KM, West MJ, Ask DM. Cost-effective treatment of constipation in the elderly. A randomized double-blind comparison of sorbitol and lactulose. Am J Med. 1990;89:597-601.
66. Miller LE, Tennilä J, Ouwehand AC. Efficacy and tolerance of lactitol supplementation for adult constipation: a systematic review and meta-analysis. Clin Exp Gastroenterol. 2014;7:241-8.
67. Ouwehand AC, Tiihonen K, Saarinen M, Putaala H, Rautonen N. Influence of a combination of Lactobacillus acidophilus NCFM and lactitol on healthy elderly: intestinal and immune parameters. Br J Nutr. 2009;101:367-75.
68. De Giorgio R, Cestari R, Corinaldesi R, et al. Use of macrogol 4000 in chronic constipation. Eur Rev Med Pharmacol Sci. 2011;15:960-6.
69. DiPalma JA, Cleveland MV, McGowan J, Herrera HL. A randomized, multicenter, placebo-controlled trial of polyethylene glycol laxative for chronic treatment of chronic constipation. Am J Gastroenterol. 2007;102:1436-41.
70. Corazziari E, Badiali D, Bazzocchi G, et al. Long term efficacy, safety, and tolerabilitity of low daily doses of isosmotic polyethylene glycol electrolyte balanced solution (PMF-100) in the treatment of functional chronic constipation. Gut. 2000;46:522-6.
71. DiPalma JA, Cleveland MB, McGowan J, Herrera HL. A comparison of polyethylene glycol laxative and placebo for relief of constipation from constipating medications. South Med J. 2007;100(11):1085-90.
72. Chapman RW, Stanghellini V, Geraint M, Halphen M. Randomized clinical trial: macrogol/PEG 3350 plus electrolytes for treatment of patients with constipation associated with irritable bowel syndrome. Am J Gastroenterol. 2013;108:1508-15.
73. Belsey JD, Geraint M, Dixon TA. Systematic review and meta analysis: polyethylene glycol in adults with non-organic constipation. Int J Clin Pract. 2010;64:944-55.
74. Crowell MD, Harris LA, Lunsford TN, Dibaise JK. Emerging drugs for chronic constipation. Expert Opin Emerg Drugs. 2009;14:493-504.
75. Crowell MD, Harris LA, Dibaise JK, Olden KW. Activation of type-2 chloride channels: a novel therapeutic target for the treatment of chronic constipation. Curr Opin Investig Drugs. 2007;8:66-70.
76. Lacy BE, Levy LC. Lubiprostone: a novel treatment for chronic constipation. Clin Interv Aging. 2008;3:357-64.
77. Barish CF, Drossman D, Johanson JF, Ueno R. Efficacy and safety of lubiprostone in patients with chronic constipation. Dig Dis Sci. 2010;55:1090-7.
78. Johanson JF, Morton D, Geenen J, Ueno R. Multicenter, 4-week, double-blind, randomized, placebo-controlled trial of lubiprostone, a locally-acting type-2 chloride channel activator, in patients with chronic constipation. Am J Gastroenterol. 2008;103:170-7.
79. Johanson JF, Ueno R. Lubiprostone, a locally acting chloride channel activator, in adult patients with chronic constipation: a double-blind, placebo-controlled, dose-ranging study to evaluate efficacy and safety. Aliment Pharmacol Ther. 2007;25:1351-61.
80. Gras-Miralles B, Cremonini F. A critical appraisal of lubiprostone in the treatment of chronic constipation in the elderly. Clin Interv Aging. 2013;8:191-200.
81. Layer P, Stanghellini V. Review article: Linaclotide for the management of irritable bowel syndrome with constipation. Aliment Pharmacol Ther. 2014;39(4):371-84.
82. Lacy BE, Levenick JM, Crowell M. Chronic constipation: new diagnostic and treatment approaches. Ther Adv Gastroenterol. 2012;5:233-47.
83. Lembo AJ, Kurtz CB, Macdougall JE, et al. Efficacy of linaclotide for patients with chronic constipation. Gastroenterology. 2010;138:886-95.
84. Rao SS, Quigley EM, Shiff SJ, et al. Effect of Linaclotide on Severe Abdominal Symptoms in Patients with Irritable Bowel Syndrome with Constipation. Clin Gastroenterol Hepatol. 2014;12:616-23.
85. De Giorgio R, Barbara G, Furness JB, Tonini M. Novel therapeutic targets for enteric nervous system disorders. Trends Pharmacol Sci. 2007;28:473-81.
86. Quigley EMM. Prucalopride: safety, efficacy and potential applications. Ther Adv Gastroenterol. 2012;5:23-30.
87. Tack J, Stanghellini V, Dubois D, Joseph A, Vandeplassche L, Kerstens R. Effect of prucalopride on symptoms of chronic constipation. Neurogastroenterol Motil. 2014;26:21-7.
88. Muller-Lissner S, Rykx A, Kerstens R, Vandeplassche L. A double-blind, placebo-controlled study of prucalopride in elderly patients with chronic constipation. Neurogastroenterol Motil. 2010;22:991-8.
89. Camilleri M, Beyens G, Kerstens R, Robinson P, Vandeplassche L. Safety assessment of prucalopride in elderly patients with constipation: A double blind, placebo-controlled study. Neurogastroenterol Motil. 2009;21:1256-63.
90. Goldberg M, Li YP, Johanson JF, et al. Clinical trial: the efficacy and tolerability of velusetrag, a selective 5-HT4 agonist with high intrinsic activity, in chronic idiopathic constipation -a 4-week, randomized, double-blind, placebo-controlled, dose-response study. Aliment Pharmacol Ther. 2010;32:1102-12.
91. Camilleri M, Vazquez-Roque MI, Burton D, et al. Pharmacodynamic effects of a novel prokinetic 5-HT receptor agonist, ATI-7505, in humans. Neurogastroenterol Motil. 2007;19:30-8.
92. Chey WD, Camilleri M, Chang L, Rikner L, Graffner H. A randomized placebo-controlled phase IIb trial of A3309, a bile acid transporter inhibitor, for chronic idiopathic constipation. Am J Gastroenterol. 2011;106:1803-12.
93. Shailubhai K, Comiskey S, Foss JA, et al. Plecanatide, an oral guanylate cyclase C agonist acting locally in the gastro- intestinal tract, is safe and well-tolerated in single doses. Dig Dis Sci. 2013;58:2580-6.
94. Miner PB, Surowitz R, Fogel R, et al. Plecanatide, a novel guanylate-cyclase C (GC-C) receptor agonist, is efficacious and safe in patients with chronic idiopathic constipation (CIC): results from a 951 patient, 12 week, multi-center trial. Digestive Diseases Week. Orlando, FL: Orange County Convention Center; 2013. p. 925.